Hyaluronic Acid Viscosupplementation Market By Course of Treatment & By Osteoarthritis 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Hyaluronic acid viscosupplementation market
Hyaluronic Acid Viscosupplementation Market Analysis: By Course of Treatment (Single Injection, Multiple Injections); By Osteoarthritis (Knee, Hip, Ankle, and Shoulder) - Forecast (2016 - 2021).
Report Code : HCR 0040
Published: 20 June, 2015   No. of pages: 180

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Osteoarthritis of the knee is the key cause of disability among people. This degenerative joint disease is caused due to wear and tear of joint’s cartilage. Joint injuries, obesity and genetic problem are other causes of osteoarthritis. Viscosupplementation is one of the treatment procedures to relieve Osteoarthritis. In this procedure, a thick fluid called hyaluronic acid is directly injected into the knee joint. The hyaluronic acid is found in synovial fluid surrounding joints that act as lubricating agent enabling smooth movement of bones. This gel-like fluid also acts as shock absorber for joint loads. This procedure helps to improve the mobility of the joints and assures more comfort level during any activity.

In this report, Global Hyaluronic Acid Viscosupplementation Market
is segmented by course of Treatment and Anatomy. The treatment of Osteoarthritis can be done by Single Injection or Multiple Injections of hyaluronic acid into the joints. The market on basis of anatomy can be divided into Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis and Shoulder Osteoarthritis.

Hyaluronic Acid Viscosupplementation Market

The market is also analyzed based on geographic regions which are grouped into Americas, Asia-Pacific (APAC), Europe as well as RoW regions. Osteoarthritis constitutes to be a growing public health problem. This disease is commonly found among adults in the U.S. Thus, the U.S. is leading in providing viscosupplementation treatment. In APAC, the market is forecast to grow since some countries like India possess high number of knee-osteoarthritis patients. Europe is the next leading region for this market. Since, there are no reimbursements in European countries such as Spain, France and other countries; the market in this region is still low.

The major companies of Hyaluronic Acid Viscosupplementation Market are:
  • Sanofi (France),
  • Fidia Pharma USA Inc. (U.S),
  • Ferring Pharmaceuticals Inc. (Switzerland),
  • Mylan Inc. (U.S),
  • Zimmer Inc. (U.S.) and many others.

The data is obtained with help of primary and secondary sources. Many questionnaires and interviews were conducted with the key companies of this market to estimate the market values. Secondary sources such as articles and medical journals were studied to have an overview of the market. Public health data has been collected from some organization such as World Health Organization that helped to analyze the entire market.
1. Hyaluronic Acid Viscosupplementation Market Overview
2. Executive Summary
3. Hyaluronic Acid Viscosupplementation Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Hyaluronic Acid Viscosupplementation - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Hyaluronic Acid Viscosupplementation - Market Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product/Market Life Cycle Analysis
   5.4. Pricing Analysis
6. Hyaluronic Acid Viscosupplementation - Market By Course of Treatment
   6.1. By Single Injection
   6.2. By Multiple Injections
7. Hyaluronic Acid Viscosupplementation - Market By Anatomy
   7.1. Knee Osteoarthritis
   7.2. Hip Osteoarthritis
   7.3. Ankle Ostereoarthritis
   7.4. Shoulder Osteoarthritis
8. Hyaluronic Acid Viscosupplementation - Market Geographic Analysis
   8.1. Introduction
   8.2. Americas
      8.2.1. Canada
      8.2.2. US
      8.2.3. Brazil
      8.2.4. Others
   8.3. Europe
      8.3.1. U.K.
      8.3.2. Germany
      8.3.3. France
      8.3.4. Spain
      8.3.5. Netherland
      8.3.6. Others  
   8.4. APAC
      8.4.1. China
      8.4.2. Japan
      8.4.3. India
      8.4.4. South Korea
      8.4.5. Australia
      8.4.6. Others
   8.5. ROW
9. Market Entropy

   9.1. New Product Launches  
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
   10.1. Euflexxa
   10.2. Fidia Farma USA Inc.
   10.3. Anika Therapeutics, Inc.
   10.4. Synvisc –One
   10.5. Supartz
   10.6. Zimmer, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

List of Tables:

Table 1. Global Hyaluronic Acid Viscosupplementation Market Value, By Region, 2015-2021 ($Million)
Table 2. Global Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Course of Treatment, (2016-2021)
Table 3. Single Injection Market Revenue ($Million), By Geography, (2016-2021)
Table 4. Multiple Injection Market Revenue ($Million), By Geography, (2016-2021)
Table 5. Global Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Anatomy, (2016-2021)
Table 6. Knee Osteoarthritis Market Revenue ($Million), By Geography, (2016-2021)
Table 7. Hip Osteoarthritis Market Revenue ($Million), By Geography, (2016-2021)
Table 8. Ankle Osteoarthritis Market Revenue ($Million), By Geography, (2016-2021)
Table 9. Shoulder Osteoarthritis Market Revenue ($Million), By Geography, (2016-2021)
Table 10. Global Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Geography, (2016-2021)
Table 11. Global Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Region, (2016-2021)
Table 12. Americas Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Course of Treatment, (2016-2021)
Table 13. Americas Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Anatomy, (2016-2021)
Table 14. Global Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Region, (2016-2021)
Table 15. Europe Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Course of Treatment, (2016-2021)
Table 16. Europe Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Anatomy, (2016-2021)
Table 17. Global Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Region, (2016-2021)
Table 18. APAC Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Course of Treatment, (2016-2021)
Table 19. APAC Hyaluronic Acid Viscosupplementation Market Revenue ($Million), By Anatomy, (2016-2021)


List of Figures:

Figure 1. Global Hyaluronic Acid Viscosupplementation Market Share, By Type, 2015 (%)
Figure 2. Number of Patents filed during 2012-16 by Companies, (%)
Figure 3. PRICING ANALYSIS (Average Selling Price) ($)
Figure 4. ROW Hyaluronic Acid Viscosupplementation Market Value, 2015-2021 ($Million)
Figure 5. Zimmer: Total Revenue, 2010-2014 ($Billion)
Figure 6. Zimmer: Total Sales, By Geography, 2014 (%)
Figure 7. Zimmer: Total Sales, By Division, 2014 (%)
Figure 8. Anika Therapeutics: Total Revenue, 2010-2014 ($Million)
Figure 9. Anika Therapeutics: Total Sales, By Geography, 2014 (%)
Figure 10. Anika Therapeutics: Total Sales, By Division, 2014 (%)
Figure 11. Ferring Pharmaceuticals: Total Revenue, 2010-2014 ($Billion)
Figure 12. Ferring Pharmaceuticals: R&D Distribution, 2014 (%)
Figure 13. Ferring Pharmaceutical: Total Sales, By Division, 2014 (%)
Figure 14. Seikagaku Corporation: Total Revenue, 2010-2014 ($Million)
Figure 15. Seikagaku Corporation: Total Sales, By Geography, 2014 (%)
Figure 16. Seikagaku Corporation: Total Sales, By Division, 2014 (%)
Figure 17. Sanofi Aventis LLC: Total Revenue, 2010-2014 ($Billion)
Figure 18. Sanofi Aventis LLC: Total Sales, By Geography, 2014 (%)
Figure 19. Sanofi Aventis LLC: Total Sales, By Division, 2014 (%)
Figure 20. Chugai Pharmaceutical Co. Ltd.: Total Revenue, 2010-2014 ($Billion)
Figure 21. Chugai Pharmaceutical Co. Ltd.: Total Sales, By Geography, 2014 (%)
Figure 22. MEDA.: Total Revenue, 2010-2014 ($Billion)
Figure 23. MEDA: Total Sales, By Geography, 2014 (%)
Figure 24. MEDA: Total Sales, By Division, 2014 (%)
Figure 25. MYLAN: Total Revenue, 2011-2015 ($Billion)
Figure 26. MYLAN: Total Sales, By Geography, 2015 (%)
Figure 27. MYLAN: Total Sales, By Division, 2015 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports